Neel Agarwal

@osumc.edu

College of Medicine
The Ohio State University Wexner Medical Center

Neel Agarwal


                              Download Compact PDF  
https://researchid.co/neelagarwal_med
Cleveland native, Columbus local, Ohio born and raised. Med student.

EDUCATION

B.S. Case Western Reserve University Biochemistry and Psychology, Minors: Public Health, Spanish, Chemistry
M.D. Ohio State College of Medicine (CO 2028)

RESEARCH, TEACHING, or OTHER INTERESTS

Urology, Surgery, Transplantation, Medicine
10

Scopus Publications

94

Scholar Citations

5

Scholar h-index

4

Scholar i10-index

Scopus Publications

  • In Reply: Time in Target Range, Sex-Specific Effects, and the Path to Clinical Integration
    Neel Agarwal, Julie St. John, Luke J. Laffin
    Journal of Clinical Hypertension, 2025
    To the Editor, Garg et al. raise questions that merit further discussion when discussing our recent publication regarding systolic blood pressure (SBP) time in target range (TTR) and incidence of major adverse cardiovascular events (MACE) [1, 2]. The authors hypothesize why men and women demonstrated different associations between SBP TTR and MACE. While baseline risk profiles and physiology differed between sexes due to PRECISION inclusion criteria, it is necessary to consider our findings within the context of the existing literature for BP lowering [3]. The Systolic Blood Pressure Intervention Trial (SPRINT) demonstrated that intensive SBP control (<120 mmHg) provided significant and comparable benefits for both men and women, and there was no statistical interaction between sex and the treatment effect (p for interaction = 0.45), indicating that the magnitude of benefit from intensive control did not differ between men and women [4]. Therefore, while the target range of 110–130 mmHg may appear to align with average female BP, the therapeutic principle of achieving this target is strongly supported for men as well. The lack of a statistically significant association in men of our cohort may reflect factors beyond the choice of target range, such as differences in medication adherence, underlying pathophysiology, or as the authors mentioned, the differential inclusion criteria. The authors also note the methodological limitations inherent in using office-based BP measurements to calculate SBP TTR, particularly the potential for misclassification in individuals with higher SBP variability due to hypertension. We concur that out-of-office assessment is crucial; however, the prognostic significance of visit-to-visit variability derived from office measurements is well-established and provides independent predictive information for MACE, even beyond mean BP levels [5-7]. Additionally, existing literature demonstrates that patients with hypertension typically have higher office-based BP measurements, which would have placed them in their appropriate TTR group due to their overall higher mean BP despite enhanced variability. The use of office-based measurements for SBP TTR is a well-established approach that reflects the data most commonly available to clinicians and researchers. The fact that this metric yielded significant associations highlights its real-world clinical utility. Further, the authors mention SBP variability as a potential confounder of TTR. Based on the formula used to calculate TTR, visit-to-visit variability, particularly over variable time intervals, is factored into its derivation [8]. Regarding the potential confounding effect of nonsteroidal anti-inflammatory drugs, it is critical to appraise that the PRECISION trial was a randomized controlled trial that inherently minimizes confounding factors, and our statistical models further adjusted for the assigned treatment arm during analysis. Finally, we wholeheartedly agree with the authors’ sentiment that the ultimate goal of this research is to improve clinical practice. We believe that by demonstrating a clear link between the consistency of SBP control over time through TTR with MACE and cardiovascular outcomes, we are providing a compelling rationale for the future clinical and practice guideline-level integration of the TTR metric. Luke J. Laffin has been a consultant and/or served on steering committees for Medtronic, Lilly, Mineralys Therapeutics, AstraZeneca, and CRISPR Therapeutics; has received research funding from AstraZeneca; and has ownership interests in LucidAct Health and Gordy Health. The other authors have no disclosures. Luke J. Laffin has received research funding from AstraZeneca.
  • Association of Systolic Blood Pressure Time in Target Range With Cardiovascular Events Among PRECISION Participants
    Neel Agarwal, Julie St. John, Vikas Sunder, Ashish Sarraju, Luke J. Laffin
    Journal of Clinical Hypertension, 2025
    Blood pressure (BP) is a dynamic vital sign with variability. Novel metrics that account for BP variability and longitudinal control are gaining interest, such as time in target range (TTR) assessments. TTR is the percentage of time a patient's BP is within a desired range. We sought to determine if systolic BP TTR was associated with major adverse cardiovascular events (MACE) among participants in the PRECISION (Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen or Naproxen) trial. PRECISION was a 24 081‐participant cardiovascular (CV) outcomes trial comparing celecoxib, naproxen, or ibuprofen in participants with increased CV risk. Systolic BP was in the target range if it was between 110 and 130 mm Hg. TTR was determined via traditional and Rosendaal linear interpolation (RLI) methods. Participants were categorized based on TTR achieved, &lt;25%, 25%–&lt;50%, 50%–&lt;75%, or ≥75%. Hazard ratios (HR) and Kaplan–Meier survival curves were generated. Twenty thousand four hundred and eighty‐seven participants had at least four BP readings available for analysis and a median follow‐up of 27.6 ± 5.4 months. The cohort had a mean baseline BP of 125.2 mm Hg and a mean systolic BP of 127.5 mm Hg when accounting for all follow‐up visits. A lower risk of MACE was observed among individuals with ≥75% TTR compared with those &lt;25% using the traditional (adjusted HR 0.70, 95% CI 0.52–0.95, p = 0.02) and RLI method (adjusted HR 0.56, 95% CI 0.43–0.75, p &lt; 0.001). More systolic BP TTR is associated with a lower risk of MACE among individuals in PRECISION.
  • Fetal alcohol spectrum disorder: an exploratory telehealth pilot group intervention for caregivers
    Kimberly Burkhart, Catherine Lipman, Neel Agarwal, Rachel Tangen, Denise Bothe
    Children S Health Care, 2025
    The Family Foundations: Behavioral, Emotional, Social, and Team-Based [B.E.S.T.] program is a novel trauma-informed intervention for caregivers of children with Fetal Alcohol Spectrum Disorders (FASD) to address emotional, behavioral, and cognitive problems. Twenty-five caregivers participated in this exploratory pilot study and completed pre- and post-intervention questionnaires. There was a significant decrease in child externalizing behavioral problems and total problems (p < .01). There was a significant decrease in caregiver stress (p < .01) and an increase in self-reported parenting confidence (p < .01). Mixed results were obtained for change in child social functioning. Further evaluation with a control group and larger sample size is needed to further assess the effectiveness of the program.
  • Barriers to dental utilization among Medicaid-enrolled young children from primary care practices in Northeast Ohio
    David Selvaraj, Neel Agarwal, Jeffrey M. Albert, Suchitra Nelson
    Community Dentistry and Oral Epidemiology, 2024
    ObjectivesTo evaluate the individual and community factors that contribute to dental utilization among young children on Medicaid utilizing the Anderson Model and the Socio‐Ecological Framework.MethodsThis observational cross‐sectional study was conducted using baseline data (socio‐demographics, clinical dental need) from a cluster‐randomized hybrid effectiveness‐implementation trial among 1021 child–parent dyads recruited from primary care practices across northeast Ohio. The baseline data were then linked to dental Medicaid claims data (categorized as any dental visit, volume, and type in the past 12 months) and ICD‐10 codes from the child's EHR data (individual‐level) together with Dental Health Provider Shortage Area (HPSA) status and Area Deprivation Index (ADI) which were obtained at the neighbourhood‐level using home address of each dyad (community‐level). Multivariable analyses using generalized estimating equations (GEE) accounted for clustering by practice, and models included individual‐level alone, and individual + community‐level factors to evaluate their effects on dental utilization.ResultsMedicaid claims data indicated that among the 1021 children (mean age: 4.3 ± 1.1 years; 54.4% males; 43.8% Black, Non‐Hispanic), a majority of children were seeing the dentist at least once a year by the age of 4 (56.1%). The mean ADI of their neighbourhoods was 109.22 (20.2) and 27.5% lived in a HPSA area. The GEE analyses revealed that individual factors such as older children, parents being married, and continuous Medicaid enrollment were associated with significantly higher dental utilization. Among community factors, being in a HPSA had an OR = 1.53 (CI: 1.03, 2.27) associated with higher dental utilization.ConclusionsBeing in a HPSA was associated with higher dental utilization possibly due to dentists or safety net dental clinics in these areas accepting Medicaid‐eligible children.
  • Blood Pressure Time in Target Range and its Impact on Clinical Outcomes
    Astefanos Al-Dalakta, Chadi Tabaja, Issam Motairek, Abdel Hadi El Hajjar, Neel Agarwal, Julie St. John, Luke J. Laffin
    Current Cardiology Reports, 2024
    Purpose of Review To examine the concept of time in target range for blood pressure (BP) management, exploring its calculation methods, implications for patient outcomes, and potential use in patient care. Recent Findings Recent post-hoc analyses of clinical trials and observational studies highlight the importance of BP time in target range in predicting cardiovascular outcomes. Higher time in target range correlates with reduced risks of major adverse cardiovascular events including heart failure, stroke, myocardial infarction and all-cause mortality. Additionally, longer time in target range decreases the risk of incident atrial fibrillation and risk of developing dementia. Summary BP time in target range is a novel metric offering valuable insights into BP control and its impact on clinical outcomes. Higher time in target range is consistently associated with better cardiovascular outcomes across various patient populations. However, the clinical application of BP time in target range requires further investigation through prospective clinical trials and real-world studies. Integrating wearable devices for continuous BP monitoring could enhance the practical utility of BP time in target range in hypertension management.
  • Regulation of Intestinal Inflammation by Walnut-Derived Bioactive Compounds
    Kexin Dai, Neel Agarwal, Alexander Rodriguez-Palacios, Abigail Basson
    Nutrients, 2024
    Walnuts (Juglans regia L.) have shown promising effects in terms of ameliorating inflammatory bowel disease (IBD), attributed to their abundant bioactive compounds. This review comprehensively illustrates the key mechanisms underlying the therapeutic potential of walnuts in IBD management, including the modulation of intestinal mucosa permeability, the regulation of inflammatory pathways (such as NF-kB, COX/COX2, MAPCK/MAPK, and iNOS/NOS), relieving oxidative stress, and the modulation of gut microbiota. Furthermore, we highlight walnut-derived anti-inflammatory compounds, such as polyunsaturated fatty acids (PUFA; e.g., ω-3 PUFA), tocopherols, phytosterols, sphingolipids, phospholipids, phenolic compounds, flavonoids, and tannins. We also discuss unique anti-inflammatory compounds such as peptides and polysaccharides, including their extraction and preparation methods. Our review provides a theoretical foundation for dietary walnut supplementation in IBD management and provides guidance for academia and industry. In future, research should focus on the targeted isolation and purification of walnut-derived anti-inflammatory compounds or optimizing extraction methods to enhance their yields, thereby helping the food industry to develop dietary supplements or walnut-derived functional foods tailored for IBD patients.
  • Adoption of New Oral Health Interventions in Primary Care: Qualitative Findings
    Gloria C. Bales, Shelley Curtan, Neel Agarwal, Sarah D. Ronis, Suchitra Nelson
    Ajpm Focus, 2024
    Introduction: This is the first study to use the Common-Sense Model of Self-Regulation theory for oral health interventions in pediatric practices. The objective of this qualitative study was to assess adoption and implementation of theory-based multilevel oral health interventions, by clinicians (pediatricians and nurse practitioners) participating in a cluster randomized clinical trial, to create an oral health toolkit for widespread dissemination into pediatric practices. Methods: Semistructured interviews were conducted at the conclusion of the cluster randomized clinical trial with 21 clinicians from 9 practices participating in the intervention arm. Clinicians in this arm received Common-Sense Model of Self-Regulation theory-based education and resources to deliver oral health interventions to parents/caregivers and document in electronic medical record. Semistructured interview questions were based on the Diffusion of Innovations Theory, assessing adoption and implementation. The interviews were coded using NVivo (QRS International) software. Main themes were identified using a thematic analysis approach. Results: Five themes identified from the interviews included strengths of theory-based oral health training for clinicians, oral health resources to improve quality of care, considerations for efficient future implementation, financial considerations, and parent benefits and challenges. Clinicians found that the theory-based training and resources increased knowledge and confidence when addressing oral health with parents and required only ≤2 minutes in their workflow with no financial consequences. Clinicians reported an increase in oral health awareness among parents but suggested an overall need for more pediatric dentists. Conclusions: The Common-Sense Model of Self-Regulation theory-based education and resources were well received by clinicians and perceived to be beneficial without adverse impact on workflow or practice finances. An online toolkit is planned because these oral health interventions can be successfully implemented and delivered in medical settings.
  • The PML1-WDR5 axis regulates H3K4me3 marks and promotes stemness of estrogen receptor-positive breast cancer
    Chun-Peng Pai, Han Wang, Darcie D. Seachrist, Neel Agarwal, Joshua A. Adams, Zhenghao Liu, Ruth A. Keri, Kaixiang Cao, William P. Schiemann, Hung-Ying Kao
    Cell Death and Differentiation, 2024
    The alternative splicing of PML precursor mRNA gives rise to various PML isoforms, yet their expression profile in breast cancer cells remains uncharted. We discovered that PML1 is the most abundant isoform in all breast cancer subtypes, and its expression is associated with unfavorable prognosis in estrogen receptor-positive (ER+) breast cancers. PML depletion reduces cell proliferation, invasion, and stemness, while heterologous PML1 expression augments these processes and fuels tumor growth and resistance to fulvestrant, an FDA-approved drug for ER+ breast cancer, in a mouse model. Moreover, PML1, rather than the well-known tumor suppressor isoform PML4, rescues the proliferation of PML knockdown cells. ChIP-seq analysis reveals significant overlap between PML-, ER-, and Myc-bound promoters, suggesting their coordinated regulation of target gene expression, including genes involved in breast cancer stem cells (BCSCs), such as JAG1 , KLF4 , YAP1 , SNAI1 , and MYC . Loss of PML reduces BCSC-related gene expression, and exogenous PML1 expression elevates their expression. Consistently, PML1 restores the association of PML with these promoters in PML -depleted cells. We identified a novel association between PML1 and WDR5, a key component of H3K4 methyltransferase (HMTs) complexes that catalyze H3K4me1 and H3K4me3. ChIP-seq analyses showed that the loss of PML1 reduces H3K4me3 in numerous loci, including BCSC-associated gene promoters. Additionally, PML1, not PML4, re-establishes the H3K4me3 mark on these promoters in PML -depleted cells. Significantly, PML1 is essential for recruiting WDR5, MLL1, and MLL2 to these gene promoters. Inactivating WDR5 by knockdown or inhibitors phenocopies the effects of PML1 loss, reducing BCSC-related gene expression and tumorsphere formation and enhancing fulvestrant’s anticancer activity. Our findings challenge the conventional understanding of PML as a tumor suppressor, redefine its role as a promoter of tumor growth in breast cancer, and offer new insights into the unique roles of PML isoforms in breast cancer.
  • Association of pulse pressure with death, myocardial infarction, and stroke among cardiovascular outcome trial participants
    Neel Agarwal, Julie St. John, Erik H. Van Iterson, Luke J. Laffin
    American Journal of Preventive Cardiology, 2024
    Prior evidence demonstrates that pulse pressure (PP), a surrogate marker of arterial stiffness, is an independent risk factor for mortality and major adverse cardiovascular (CV) events. The study aimed to identify the association of PP with death, myocardial infarction, and stroke among participants enrolled in large CV outcome clinical trials and determine if this association was impacted by pre-existing CV disease, or specific CV risk factors. A total of 65,382 individuals, ages 19 to 98 years, that were enrolled in one of five CV outcome trials were analyzed. Baseline demographics, history, blood pressures, medications were collected. Univariate and multivariable analyses were conducted to explore temporal patterns, risks, and adjusted survival rates. Mean baseline PP was 52±12 mmHg. For every 10 mmHg increase in PP, there was an increased risk of death, stroke, or myocardial infarction (hazard ratio (HR) 1.11, 95% CI 1.08 to 1.14, p < 0.001). Similarly, a PP ≥ 60 mmHg demonstrated an HR of 1.27 (95% CI 1.19 to 1.36, p < 0.001) compared with PP<60 mmHg. A similar association existed for all subgroups analyzed except for participants with a history of stroke where increasing PP did not increase risk (HR 1.02, 95% CI 0.95 to 1.10, p=0.53). PP was a better predictor of adverse outcomes when compared to both systolic and diastolic blood pressures using the AIC and C-index. Among participants enrolled in CV outcome trials, baseline PP is associated with increased risk of death, myocardial infarction, and stroke for those with pre-existing CV disease and risk factors with the exception of a prior history of stroke.
  • A Scoping Review of Trauma-Informed Pediatric Interventions in Response to Natural and Biologic Disasters
    Kimberly Burkhart, Neel Agarwal, Sehyun Kim, Mandy Neudecker, Carolyn Ievers-Landis
    Children, 2023
    A scoping review was performed of trauma-informed psychological interventions to treat anxiety, depression, and posttraumatic stress symptoms in youth in response to natural/biologic disasters. The specific aims were to identify psychosocial interventions used in response to natural/biologic disasters, report the interventions’ effectiveness, describe limitations, and provide treatment recommendations and future directions. Of the 45 studies extracted, 28 were on natural disasters and 17 on biologic disasters with the majority related to the COVID-19 pandemic. The most commonly implemented interventions were Cognitive Behavioral Therapy (CBT), Trauma-Focused Cognitive Behavioral Therapy (TF-CBT), and eye movement desensitization and reprocessing (EMDR). The UCLA Posttraumatic Stress Disorder Reaction Index (UCLA PTSD-RI) and the Strengths and Difficulties Questionnaire (SDQ) were the most frequently used measures. Methodological rigor was varied, with 60% randomized, controlled trials. Overall, there was a significant decrease in posttraumatic stress symptoms, distress, anxiety, and depression regardless of whether the participant received CBT, TF-CBT, or EMDR. Generally, there was not a significant decrease in anxiety and depression with yoga, cognitive fear-reduction, emotion-based drawing, and community health education. Recommendations for future directions include larger-scale studies with group and on-line interventions that include younger children with moderation analyses by gender and race/ethnicity.

RECENT SCHOLAR PUBLICATIONS

  • 26-A-7969-ACC REMNANT CHOLESTEROL IS A STRONGER INDEPENDENT PREDICTOR OF INCIDENT MACE THAN NON-HDL-C AMONG PARTICIPANTS IN THE NIH “ALL OF US” COHORT
    N Agarwal, J St. John, L Laffin
    Journal of the American College of Cardiology 87 (13_Supplement), A164-A164 , 2026
    2026
  • Fetal alcohol spectrum disorder: an exploratory telehealth pilot group intervention for caregivers
    K Burkhart, C Lipman, N Agarwal, R Tangen, D Bothe
    Children's Health Care 54 (4), 449-462 , 2025
    2025
    Citations: 3
  • In Reply: Time in Target Range, Sex-Specific Effects, and the Path to Clinical Integration
    N Agarwal, JS John, LJ Laffin
    The Journal of Clinical Hypertension 27 (10), e70170 , 2025
    2025
  • Association of Systolic Blood Pressure Time in Target Range With Cardiovascular Events Among PRECISION Participants
    N Agarwal, J St. John, V Sunder, A Sarraju, LJ Laffin
    The Journal of Clinical Hypertension 27 (7), e70009 , 2025
    2025
    Citations: 3
  • Association of Blood Pressure Time in Target Range with Outcomes Among NIH" All of Us” Cohort
    N Agarwal, J St John, L Laffin
    Circulation 150 (Suppl_1), A4144351-A4144351 , 2024
    2024
  • Blood pressure time in target range and its impact on clinical outcomes
    A Al-Dalakta, C Tabaja, I Motairek, AH El Hajjar, N Agarwal, J St. John, ...
    Current cardiology reports 26 (10), 1145-1151 , 2024
    2024
    Citations: 8
  • Barriers to dental utilization among Medicaid‐enrolled young children from primary care practices in Northeast Ohio
    D Selvaraj, N Agarwal, JM Albert, S Nelson
    Community dentistry and oral epidemiology 52 (5), 699-707 , 2024
    2024
    Citations: 1
  • Regulation of intestinal inflammation by Walnut-Derived bioactive compounds
    K Dai, N Agarwal, A Rodriguez-Palacios, AR Basson
    Nutrients 16 (16), 2643 , 2024
    2024
    Citations: 12
  • The PML1-WDR5 axis regulates H3K4me3 marks and promotes stemness of estrogen receptor-positive breast cancer
    CP Pai, H Wang, DD Seachrist, N Agarwal, JA Adams, Z Liu, RA Keri, ...
    Cell Death & Differentiation 31 (6), 768-778 , 2024
    2024
    Citations: 20
  • Adoption of new oral health interventions in primary care: qualitative findings
    GC Bales, S Curtan, N Agarwal, SD Ronis, S Nelson
    AJPM focus 3 (3), 100214 , 2024
    2024
    Citations: 2
  • SYSTOLIC BLOOD PRESSURE TIME IN TARGET RANGE PREDICTS MAJOR ADVERSE CARDIOVASCULAR EVENTS AMONG PRECISION TRIAL PARTICIPANTS
    L Laffin, N Agarwal, JS John
    Journal of the American College of Cardiology 83 (13_Supplement), 1761-1761 , 2024
    2024
  • Association of pulse pressure with death, myocardial infarction, and stroke among cardiovascular outcome trial participants
    N Agarwal, JS John, EH Van Iterson, LJ Laffin
    American Journal of Preventive Cardiology 17, 100623 , 2024
    2024
    Citations: 18
  • Association of pulse pressure with risk of major adverse cardiovascular events among cardiovascular outcome trial participants
    N Agarwal, J St Jean, EH Van Iterson, L Laffin
    European Heart Journal 44 (Supplement_2), ehad655. 2317 , 2023
    2023
    Citations: 1
  • A scoping review of trauma-informed pediatric interventions in response to natural and biologic disasters
    K Burkhart, N Agarwal, S Kim, M Neudecker, CE Ievers-Landis
    Children 10 (6), 1017 , 2023
    2023
    Citations: 26
  • ASSOCIATION OF PULSE PRESSURE AND MORTALITY IN PATIENTS WITH CHRONIC KIDNEY DISEASE
    N Agarwal, EH Van Iterson, L Laffin
    Journal of the American College of Cardiology 81 (8_Supplement), 1829-1829 , 2023
    2023
  • MODELING THE PRESCRIPTION DRUG EPIDEMIC WITH MATHEMATICAL FUNCTIONS
    N Agarwal
    The Ohio Journal of Science 118 (1), A20-A20 , 2018
    2018

MOST CITED SCHOLAR PUBLICATIONS

  • A scoping review of trauma-informed pediatric interventions in response to natural and biologic disasters
    K Burkhart, N Agarwal, S Kim, M Neudecker, CE Ievers-Landis
    Children 10 (6), 1017 , 2023
    2023
    Citations: 26
  • The PML1-WDR5 axis regulates H3K4me3 marks and promotes stemness of estrogen receptor-positive breast cancer
    CP Pai, H Wang, DD Seachrist, N Agarwal, JA Adams, Z Liu, RA Keri, ...
    Cell Death & Differentiation 31 (6), 768-778 , 2024
    2024
    Citations: 20
  • Association of pulse pressure with death, myocardial infarction, and stroke among cardiovascular outcome trial participants
    N Agarwal, JS John, EH Van Iterson, LJ Laffin
    American Journal of Preventive Cardiology 17, 100623 , 2024
    2024
    Citations: 18
  • Regulation of intestinal inflammation by Walnut-Derived bioactive compounds
    K Dai, N Agarwal, A Rodriguez-Palacios, AR Basson
    Nutrients 16 (16), 2643 , 2024
    2024
    Citations: 12
  • Blood pressure time in target range and its impact on clinical outcomes
    A Al-Dalakta, C Tabaja, I Motairek, AH El Hajjar, N Agarwal, J St. John, ...
    Current cardiology reports 26 (10), 1145-1151 , 2024
    2024
    Citations: 8
  • Fetal alcohol spectrum disorder: an exploratory telehealth pilot group intervention for caregivers
    K Burkhart, C Lipman, N Agarwal, R Tangen, D Bothe
    Children's Health Care 54 (4), 449-462 , 2025
    2025
    Citations: 3
  • Association of Systolic Blood Pressure Time in Target Range With Cardiovascular Events Among PRECISION Participants
    N Agarwal, J St. John, V Sunder, A Sarraju, LJ Laffin
    The Journal of Clinical Hypertension 27 (7), e70009 , 2025
    2025
    Citations: 3
  • Adoption of new oral health interventions in primary care: qualitative findings
    GC Bales, S Curtan, N Agarwal, SD Ronis, S Nelson
    AJPM focus 3 (3), 100214 , 2024
    2024
    Citations: 2
  • Barriers to dental utilization among Medicaid‐enrolled young children from primary care practices in Northeast Ohio
    D Selvaraj, N Agarwal, JM Albert, S Nelson
    Community dentistry and oral epidemiology 52 (5), 699-707 , 2024
    2024
    Citations: 1
  • Association of pulse pressure with risk of major adverse cardiovascular events among cardiovascular outcome trial participants
    N Agarwal, J St Jean, EH Van Iterson, L Laffin
    European Heart Journal 44 (Supplement_2), ehad655. 2317 , 2023
    2023
    Citations: 1
  • 26-A-7969-ACC REMNANT CHOLESTEROL IS A STRONGER INDEPENDENT PREDICTOR OF INCIDENT MACE THAN NON-HDL-C AMONG PARTICIPANTS IN THE NIH “ALL OF US” COHORT
    N Agarwal, J St. John, L Laffin
    Journal of the American College of Cardiology 87 (13_Supplement), A164-A164 , 2026
    2026
  • In Reply: Time in Target Range, Sex-Specific Effects, and the Path to Clinical Integration
    N Agarwal, JS John, LJ Laffin
    The Journal of Clinical Hypertension 27 (10), e70170 , 2025
    2025
  • Association of Blood Pressure Time in Target Range with Outcomes Among NIH" All of Us” Cohort
    N Agarwal, J St John, L Laffin
    Circulation 150 (Suppl_1), A4144351-A4144351 , 2024
    2024
  • SYSTOLIC BLOOD PRESSURE TIME IN TARGET RANGE PREDICTS MAJOR ADVERSE CARDIOVASCULAR EVENTS AMONG PRECISION TRIAL PARTICIPANTS
    L Laffin, N Agarwal, JS John
    Journal of the American College of Cardiology 83 (13_Supplement), 1761-1761 , 2024
    2024
  • ASSOCIATION OF PULSE PRESSURE AND MORTALITY IN PATIENTS WITH CHRONIC KIDNEY DISEASE
    N Agarwal, EH Van Iterson, L Laffin
    Journal of the American College of Cardiology 81 (8_Supplement), 1829-1829 , 2023
    2023
  • MODELING THE PRESCRIPTION DRUG EPIDEMIC WITH MATHEMATICAL FUNCTIONS
    N Agarwal
    The Ohio Journal of Science 118 (1), A20-A20 , 2018
    2018